Back

Management of rheumatic diseases in the times of COVID-19 pandemic- perspectives of rheumatology practitioners from India

2020-04-07 rheumatology Title + abstract only
View on medRxiv
Show abstract

ObjectiveThe Coronavirus disease 19 (COVID-19) pandemic has led to widespread concerns about the risk of infection in patients with rheumatic diseases (RD) receiving disease modifying ant-rheumatic drugs (DMARDs) and other immunosuppressants (IS). MethodsA SurveyMonkey(R) based electronic survey was conducted amongst members of the Indian Rheumatology Association to understand the need for changes in prevailing practices. ResultsOf the 861 invitees, 221 responded. In the wake of the pandemic, ...

Predicted journal destinations